HUMORAL AND CELLULAR IMMUNOGENICITY OF THE THIRD DOSE OF MRNA VACCINES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS ON BELIMUMAB

被引：0
|
作者：
Luca, Q. [1 ]
De Marchi, G. [1 ]
Domenis, R. [2 ]
Cabas, N. [1 ]
Guella, S. [1 ]
Paradiso, A. [2 ]
Fabro, C. [1 ]
Beltrami, A. P. [2 ]
De Vita, S. [1 ]
Curcio, F. [2 ]
机构：
[1] Acad Hosp Santa Maria della Misericordia, Div Rheumatol, Dept Med DAME, I-33100 Udine, Italy
[2] Acad Hosp Santa Maria della Misericordia, Inst Clin Pathol, ASUFC, Dept Med DAME, I-33100 Udine, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Systemic lupus erythematosus; COVID; Diagnostic tests;
D O I：
10.1136/annrheumdis-2023-eular.5645
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0548
引用
收藏
页码：539 / 540
页数：2
相关论文
共 50 条
  • [1] Humoral and T-Cell Mediated Response after the Third Dose of mRNA Vaccines in Patients with Systemic Lupus Erythematosus on Belimumab
    Quartuccio, Luca
    De Marchi, Ginevra
    Domenis, Rossana
    Cabas, Nicola
    Guella, Silvia
    Paradiso, Antonella
    Fabro, Cinzia
    Beltrami, Antonio Paolo
    De Vita, Salvatore
    Curcio, Francesco
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (03)
  • [2] Can the dose of belimumab be reduced in patients with systemic lupus erythematosus?
    Rua-Figueroa, Inigo
    Altabas-Gonzalez, Irene
    Mourino, Coral
    Roberts, Karen
    Hernandez-Martin, Andrea
    Casafont-Sole, Ivette
    Font-Urgelles, Judit
    Roman-Ivorra, Jose A.
    Navarro, Marta de la Rubia
    Galindo-Izquierdo, Maria
    Salman-Monte, Tarek C.
    Narvaez, Javier
    Vidal-Montal, Paola
    Garcia-Villanueva, Maria Jesus
    Garrote-Corral, Sandra
    Blazquez-Canamero, Maria Angeles
    Fernandez-Cid, Carlos Marras
    Piqueras-Garcia, Maria
    Martinez-Barrio, Julia
    Sanchez-Lucas, Marina
    Cortes-Hernandez, Josefina
    Penzo, Eleonora
    Calvo-Alen, Jaime
    de Dios, Juan Ramon
    Alvarez-Rodriguez, Belen
    Vasques-Rocha, Margarida
    Tomero, Eva
    Menor-Almagro, Raul
    Gandia, Myriam
    Gomez-Puerta, Jose A.
    Frade-Sosa, Beatriz
    Ramos-Giraldez, Consuelo
    Trapero-Perez, Carmen
    Diez, Elvira
    Moriano, Clara
    Munoz-Jimenez, Alejandro
    Pego-Reigosa, Jose Maria
    RHEUMATOLOGY, 2024,
  • [3] Immunogenicity and safety of inactivated and mRNA COVID-19 vaccines in patients with systemic lupus erythematosus
    So, Ho
    Li, Tena
    Chan, Vivien
    Lai-Shan Tam
    Chan, Paul K. S.
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2022, 14
  • [4] IMMUNOGENICITY AND SAFETY OF INACTIVATED AND MRNA COVID-19 VACCINES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    So, H.
    Li, T. K.
    Chan, V.
    Tam, L. S.
    Chan, P. K.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 675 - 675
  • [5] Immunogenicity and Safety of mRNA Anti-SARS-CoV-2 Vaccines in Patients with Systemic Lupus Erythematosus
    Mormile, Ilaria
    Della Casa, Francesca
    Petraroli, Angelica
    Furno, Alessandro
    Granata, Francescopaolo
    Portella, Giuseppe
    Rossi, Francesca Wanda
    de Paulis, Amato
    VACCINES, 2022, 10 (08)
  • [6] Belimumab for Systemic Lupus Erythematosus
    Hahn, Bevra Hannahs
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (16): : 1528 - 1535
  • [7] Effect of belimumab in patients with systemic lupus erythematosus treated with low dose or no corticosteroids
    Lee, Yeo-Jin
    Ahn, Soo Min
    Hong, Seokchan
    Oh, Ji-Seon
    Lee, Chang-Keun
    Yoo, Bin
    Kim, Yong-Gil
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2024, 39 (02): : 338 - 346
  • [8] Belimumab in systemic lupus erythematosus
    Vilas-Boas, Andreia
    Morais, Sandra A.
    Isenberg, David A.
    RMD OPEN, 2015, 1 (01):
  • [9] Belimumab for systemic lupus erythematosus
    Singh, Jasvinder A.
    Shah, Nipam P.
    Mudano, Amy S.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (02):
  • [10] Belimumab In Systemic Lupus Erythematosus
    Burness, Celeste B.
    McCormack, Paul L.
    DRUGS, 2011, 71 (18) : 2435 - 2444
12345